Durable complete remissions in HIV-associated Hodgkin lymphoma after treatment with only one cycle of chemotherapy complicated by sepsis.

Abstract

The infiltration of nonmalignant cells surrounding the Reed-Sternberg cells within the tumors of Hodgkin lymphoma (HL) might be central to the pathophysiology of the disease. Severe sepsis results in a flood of cytokines that activate the immune system and is associated with generalized lymphocyte apoptosis. We report on 2 patients with HIV infection and HL who achieved durable complete remissions following only one cycle of chemotherapy that was complicated by neutropenic sepsis. An understanding of the pathophysiology of sepsis and immunologic activation that appear to have led to these long-term remissions might lead to novel therapeutic approaches for patients with HL.

• Authors: Peter Martin, John P Leonard, Morton Coleman, Richard R Furman
• Journal: Clinical lymphoma & myeloma (Clin Lymphoma Myeloma) Vol. 9 Issue 3 Pg. 247-9 (Jun 2009) ISSN: 1938-0712 [Electronic] United States
• PMID: 19525196 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antineoplastic Agents
• Immunosuppressive Agents

Topics

• Adult
• Antineoplastic Agents (therapeutic use)
• HIV Infections (complications, therapy)
• Hodgkin Disease (complications, therapy, virology)
• Humans
• Immunosuppressive Agents (therapeutic use)
• Immunotherapy (methods)
• Lymphoma, AIDS-Related (therapy, virology)
• Male
• Middle Aged
• Remission Induction
• Sepsis (complications)
• Treatment Outcome